于霞，女，博士研究生，副研究員，北京市結(jié)核病胸部腫瘤研究所碩士研究生導(dǎo)師；本科畢業(yè)于中國醫(yī)科大學(xué)，碩士畢業(yè)于北京市結(jié)核病胸部腫瘤研究所，博士畢業(yè)于北京協(xié)和醫(yī)學(xué)院病原生物學(xué)研究所。

主要從事分枝桿菌實(shí)驗(yàn)室診斷及耐藥機(jī)制研究。先后主持國家自然科學(xué)基金、十三五傳染病重大專項(xiàng)子任務(wù)、北京市自然科學(xué)基金、首都衛(wèi)生科研發(fā)展專項(xiàng)等科研項(xiàng)目。入選通州區(qū)“兩高”人才工程�，F(xiàn)任中華醫(yī)學(xué)會(huì)結(jié)核病學(xué)分會(huì)、中國防癆協(xié)會(huì)、中國防癆雜志等學(xué)術(shù)委員；以第一作者或通訊作者發(fā)表論文20余篇，其中SCI論文20篇；參與編寫專著2部。

代表論文：（#第一作者；*通訊作者）

1. Zhang Z#, Du J#, Liu T#, Wang F, Jia J, Dong L, Zhao L, Xue Y, Jiang G, Yu X*, Huang H*. 2021. EasyNAT MTC assay: A simple, rapid, and low-cost cross-priming amplification method for the detection of mycobacterium tuberculosis suitable for point-of-care testing. Emerg Microbes Infect 10:1530-1535

2. Yu X#, Gao X#*, Zhu K#, Yin H, Mao X, Wojdyla JA, Qin B, Huang H, Wang M, SunYC*, Cui S*. 2020. Characterization of a toxin-antitoxin system in Mycobacterium tuberculosis suggests neutralization by phosphorylation as the antitoxicity mechanism. Commun Biol 3:216.

3.Yu X#, Gao X#, Li C#, Luo J, Wen S, Zhang T, Ma Y, Dong L, Wang F, Huang H*. 2019. In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China. Antimicrob Agents Chemother 63.

4Yu X, Wang G, Chen S, Wei G, Shang Y, Dong L, Schon T, Moradigaravand D, Parkhill J, Peacock SJ, Koser CU, Huang H*. 2016. Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Antimicrob Agents Chemother 60:5232-7.

5.Yu X, Liu P, Liu G, Zhao L, Hu Y, Wei G, Luo J, Huang H*. 2016. The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis. J Infect 73:558-567.